| hPL | human placental lactogen; human platelet lactogen |
|---|---|
| HPV | Hemophilus pertussis vaccine; hepatic portal vein; human papillomavirus; human parvovirus; hypoxic p... |
| HRV | heart rate variability; human reovirus; human rotavirus |
| HSP | Health Systems Plan; heat shock protein; hemostatic screening profile; Henoch-Schonlein purpura; her... |
| HTL | hamster tumor line; hearing threshold level; high-L-leucine transport; histotechnologist; human T-ce... |
| human lymphocyte antigen | A system designation for the gene products of at least four linked loci (A, B, C, and D) and a member of subloci on the sixth human chromosome which have been shown to have a strong influence on human allotransplantation, transfusions in refractory patients, and certain disease associations; more than 50 alleles are recognised, most of which are at loci HLA-A and HLA-B; autosomal dominant inheritance. (05 Mar 2000) |
|---|---|
| human measles immune serum | Obtained from the blood of a healthy person who has survived an attack of measles. Synonym: measles convalescent serum. (05 Mar 2000) |
| human menopausal gonadotropin | A hormone of pituitary originally obtained from the urine of postmenopausal women now produced synthetically; used to induce ovulation. See: menotropins. (05 Mar 2000) |
| human normal immunoglobulin | A preparation of the proteins of liquid human plasma, containing the antibodies of normal adults; it is obtained from pooled liquid human plasma from a number of donors and may be prepared by precipitation with organic solvents under controlled conditions of pH, ionic strength, and temperature. Synonym: human normal immunoglobulin. (05 Mar 2000) |
| human pertussis immune serum | The sterile serum prepared from the pooled blood of healthy adult human beings who have received repeated courses of phase I pertussis vaccine; administered intravenously or intramuscularly for the prophylaxis or treatment of whooping cough. (05 Mar 2000) |
| human plasma protein fraction | A sterile solution of selected proteins derived from the blood plasma of adult human donors, containing 4.5 to 5.5 g of protein per 100 ml, of which 83 to 90% is albumin and the remainder is alpha-and beta-globulins; used as a blood volume supporter. (05 Mar 2000) |
| human rights | The rights of the individual to cultural, social, economic, and educational opportunities as provided by society, e.g., right to work, right to education, and right to social security. (12 Dec 1998) |
| human scarlet fever immune serum | Scarlet fever convalescent serum, obtained from healthy persons who have survived an attack of scarlet fever. (05 Mar 2000) |
| human serum | See: dried human serum, normal human serum. (05 Mar 2000) |
| human serum jaundice | An obsolete name for hepatitis transmitted parenterally, usually by blood or blood products; usually due to hepatitis B. (05 Mar 2000) |
| human thioesterase | <enzyme> Homologous to e. Coli thioesterase II; not similar to animal thioesterases I or II; genbank x86032 Registry number: EC 3.1.2.- (26 Jun 1999) |
| human thrombin | Thrombin obtained from human plasma by precipitation with suitable salts and organic solvents; same uses as thrombin. (05 Mar 2000) |
| pyridoxine deficiency | A nutritional condition produced by a deficiency of pyridoxine in the diet, characterised by dermatitis, glossitis, cheilosis, and stomatitis. Marked deficiency causes irritability, weakness, depression, dizziness, peripheral neuropathy, and seizures. In infants and children typical manifestations are diarrhoea, anaemia, and seizures. Increasingly recognised as a cause is prolonged therapy with certain medications, among them isoniazid, cycloserine, and l-dopa. (12 Dec 1998) |
| pyruvate carboxylase deficiency | An autosomal recessive pyruvate metabolism disorder resulting from absent or deficient expression of pyruvate carboxylase activity. Decreased production of oxaloacetate leads to decreased gluconeogenesis, thereby causing fasting hypoglycaemia, lactic acid acidosis, and decreased synthesis of amino acid neurotransmitters. Clinical presentations include acidosis, ataxia, mental retardation; sometimes co-occurs with leigh disease. (12 Dec 1998) |
| pyruvate dehydrogenase complex deficiency | An autosomal recessive pyruvate metabolism disorder resulting from deficient enzyme activity in one of several proteins of pyruvate dehydrogenase complex, resulting in deficiency of acetyl CoA. Deficiency in acetyl CoA product reduces the synthesis of acetylcholine, thereby causing neurological abnormalities. Clinical presentations include lactic acidosis, mental retardation, and ataxia. (12 Dec 1998) |